Lateral assay device

Ended Purchase Order Awarded Last action

Contract number
75D30121P12824
Awardee
Awarding agency
Obligated
$249,950

Award facts

Opportunity
  • 75D30121Q74006 Solicitation number
Contract value 100% obligated
$249,950.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $249,950

About this award

The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,950.00 firm fixed price purchase order to Nanocomposix, Inc. for the development of a Lateral Assay Device. Nanocomposix is a manufacturer of engineered nanoparticles that has previously supported federal contracts for lateral flow assays, vaccines, and diagnostics. The contract is not set aside for any socioeconomic program. Nanocomposix has produced pilot lots for clinical trials as a subcontractor and has also received prior awards from the National Institutes of Health, Food and Drug Administration, and Department of Defense.

Quick answers

Who was awarded contract 75D30121P12824?

75D30121P12824 was awarded to Nanocomposix, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 23, 2021.

How much is contract 75D30121P12824 worth?

The government has obligated $249,950 on 75D30121P12824.

Was contract 75D30121P12824 competed?

The extent of competition for 75D30121P12824 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award